Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by aldube30on Sep 29, 2016 4:05pm
84 Views
Post# 25292268

RE:RE:RE:RE:RE:RE:RE:Last month

RE:RE:RE:RE:RE:RE:RE:Last monthYou're wrong. Look again and see what happen when they judge that the overcontributions are done deliberely. The only sources I got are in french, so I guess it wouldn't help anyone here. 

I work in an financial institution and I looked into CRA fiscal information. 

By the way, Lith just post something about the «special tax». 

Somehow, people that use TFSA to invest can «freeze» their maximum cotisation rights by retiring every dollars that are over residual rights.

I mean ;
2016 full rights are 46,5K$. You used 100% of your rights to invest. 

At the end of the year, your investment is now worth 70K$.

If you retire the excedant (70K$ - 46,5K$) before the end of 2016, few days before the end of 2016, you are going to get your maximum cotisation freeze at 70K$ plus annual rights of 2017.

Early in 2017 you put your money back in your TFSA, but you now have 70K$ rights + annual cotisation rights as to get only 46,5K$ + annual right with 23,5K$ in profits that aren't converted in «rights». 

The plus-value of doing this instead of keeping it in your TFSA at the end of 2016 is that if your investment fall in 2017 you are gonna lose your 23,5K$ rights because you hadn't retire it sometimes in the past.


Bullboard Posts